Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2207-2212

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*RHODANINE
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2207-2212.)
© 1995 American Heart Association, Inc.


Articles

Aldose Reductase Inhibitor Prevents Hyperproliferation and Hypertrophy of Cultured Rat Vascular Smooth Muscle Cells Induced by High Glucose

Kenichi Yasunari; Masakazu Kohno; Hiroaki Kano; Koji Yokokawa; Takeshi Horio; Junichi Yoshikawa

From the First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.

Abstract Vascular remodeling is a key process in the pathophysiology of atherosclerosis. Recent evidence suggests that high glucose levels may function as a vascular smooth muscle growth and proliferation–promoting substance. To explore the role of the polyol pathway in this process, we examined the effect of an aldose reductase inhibitor (ARI), epalrestat, on the growth characteristics of cultured rat vascular smooth muscle cells (VSMCs). Epalrestat (10 nmol/L, 1 µmol/L) significantly suppressed the high glucose–induced proliferative effect as measured by [3H]thymidine incorporation by 67% and 82% in cell number, suggesting ARI as an antimitogenic factor. In VSMCs, epalrestat (10 nmol/L, 1 µmol/L) significantly suppressed the high glucose–induced incorporation of [3H]leucine by 45% and 58% with the concomitant reduction of the cell size estimated by flowcytometry. Epalrestat (1 µmol/L) also suppressed high glucose–induced intracellular NADH/NAD+ increase and membrane-bound protein kinase C activation. These results indicate that this ARI possesses an antiproliferative and antihypertrophic action on VSMCs induced by high glucose possibly through protein kinase C suppression.


Key Words: atherosclerosis • vascular smooth muscle cells • vascular remodeling • diabetes mellitus • protein kinase C




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. N. Lavrentyev, A. M. Estes, and K. U. Malik
Mechanism of High Glucose Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells
Circ. Res., August 31, 2007; 101(5): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar
Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.
Diabetes, April 1, 2006; 55(4): 901 - 910.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava
Requirement of Aldose Reductase for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells
Diabetes, March 1, 2005; 54(3): 818 - 829.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S. K. Srivastava
Activation of Nulcear Factor-{kappa}B by Hyperglycemia in Vascular Smooth Muscle Cells Is Regulated by Aldose Reductase
Diabetes, November 1, 2004; 53(11): 2910 - 2920.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa
Pressure Promotes Angiotensin II-Mediated Migration of Human Coronary Smooth Muscle Cells Through Increase in Oxidative Stress
Hypertension, February 1, 2002; 39(2): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. A. Suzuki, M. Poot, R. G. Gerrity, and K. E. Bornfeldt
Diabetes Accelerates Smooth Muscle Accumulation in Lesions of Atherosclerosis: Lack of Direct Growth-Promoting Effects of High Glucose Levels
Diabetes, April 1, 2001; 50(4): 851 - 860.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Liu, A. Schoenkerman, and W. L. Lowe Jr.
Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells
Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E782 - E790.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yasunari, M. Kohno, H. Kano, M. Minami, and J. Yoshikawa
Aldose Reductase Inhibitor Improves Insulin-Mediated Glucose Uptake and Prevents Migration of Human Coronary Artery Smooth Muscle Cells Induced by High Glucose
Hypertension, May 1, 2000; 35(5): 1092 - 1098.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Antioxidants Improve Impaired Insulin-Mediated Glucose Uptake and Prevent Migration and Proliferation of Cultured Rabbit Coronary Smooth Muscle Cells Induced by High Glucose
Circulation, March 16, 1999; 99(10): 1370 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Mechanisms of Action of Troglitazone in the Prevention of High Glucose-Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells
Circ. Res., December 19, 1997; 81(6): 953 - 962.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Yasunari, M. Kohno, T. Hasuma, T. Horio, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Dopamine as a Novel Antimigration and Antiproliferative Factor of Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3164 - 3173.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Dopamine D1-Like Receptor Stimulation Inhibits Hypertrophy Induced by Platelet-Derived Growth Factor in Cultured Rat Renal Vascular Smooth Muscle Cells
Hypertension, January 1, 1997; 29(1): 350 - 354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, T. Horio, and J. Yoshikawa
Possible Involvement of Phospholipase D and Protein Kinase C in Vascular Growth Induced by Elevated Glucose Concentration
Hypertension, August 1, 1996; 28(2): 159 - 168.
[Abstract] [Full Text]